HLA-B*57:01 typing in a Malaysian cohort: implications of abacavir hypersensitivity in people living with HIV

被引:0
|
作者
Kalidasan, V [1 ]
Kunalan, Iswarya [1 ,2 ]
Rajasuriar, Reena [3 ,4 ]
Subbiah, Vijay Kumar [5 ]
Das, Kumitaa Theva [1 ]
机构
[1] Univ Sains Malaysia, Adv Med & Dent Inst, Dept Biomed Sci, Kepala Batas 13200, Penang, Malaysia
[2] Univ Sains Malaysia, Sch Biol Sci, Gelugor 11700, Penang, Malaysia
[3] Univ Malaya, Fac Med, Dept Med, Kuala Lumpur 50603, Malaysia
[4] Univ Malaya, Fac Med, Ctr Excellence Res AIDS CERiA, Kuala Lumpur 50603, Malaysia
[5] Univ Malaysia Sabah, Biotechnol Res Inst, Kota Kinabalu 88400, Sabah, Malaysia
关键词
abacavir; HIV; HLA-B*57:01; hypersensitivity reaction; Malaysia; PHARMACOGENETICS; ASSOCIATION; ALLELE;
D O I
10.2217/pgs-2023-0136
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Abacavir (ABC) in combination with other antiretroviral drugs, is used to treat people living with HIV (PLWH). However, it is linked to a fatal hypersensitivity reaction in susceptible individuals, and is strongly associated with the HLA-B*57:01 allele. Materials & methods: A total of 152 patients, 50 PLWH and 102 HIV-1 negative patients, were assessed for the HLA-B*57:01 allele through a sequence-specific primer PCR. Results: All PLWH tested negative for the HLA-B*57:01 allele, but two HIV-negative patients were found to have HLA-B*57, with one of them expressing the HLA-B*57:01 allele. Conclusion: Given the low prevalence of this risk allele in the population, testing for the presence of HLA-B*57:01 in PLWH may not provide significant benefit for the reported population.
引用
收藏
页码:761 / 769
页数:9
相关论文
共 50 条
  • [1] HLA-B*57 typing for detection of susceptibility to abacavir hypersensitivity
    Poole, K.
    Morris, G.
    Monteiro, E.
    Clarke, B.
    INTERNATIONAL JOURNAL OF IMMUNOGENETICS, 2007, 34 (04) : 312 - 312
  • [2] Abacavir hypersensitivity beyond HLA-B*57:01; prediction for new alleles
    Lammerts, Rosa
    Vivian, Julian
    Illing, Patricia
    Kouprie, Niels
    Bungener, Laura
    Hepkema, Bouke
    HLA, 2022, 99 (05) : 434 - 434
  • [3] RELEVANCE OF HLA-B*57:01 SCREENING FOR ABACAVIR HYPERSENSITIVITY IN NORTH INDIANS
    Kanga, Uma
    Sharma, Gaurav
    Sharma, Akanksha
    Alwadhi, Ajeet
    Abid, Mohd
    Gautam, Sashi K.
    HUMAN IMMUNOLOGY, 2019, 80 : 106 - 106
  • [4] EXTERNAL QUALITY ASSESSMENT OF HLA-B*57:01 TYPING FOR PROSPECTIVE ABACAVIR PATIENTS
    Corbin, Susan
    Darke, Christopher
    TISSUE ANTIGENS, 2012, 79 (06): : 524 - 525
  • [5] HLA-B*57:01 genotyping in the prevention of hypersensitivity to abacavir: 5 years of experience
    Ruiz-Iruela, Cristina
    Padulles-Zamora, Nuria
    Podzamczer-Palter, Daniel
    Alonso-Pastor, Arnald
    Candas-Estebanez, Beatriz
    Alia-Ramos, Pedro
    Padro-Miquel, Ariadna
    PHARMACOGENETICS AND GENOMICS, 2016, 26 (08): : 390 - 396
  • [6] RELEVANCE OF HLA-B*57:01 SCREENING FOR ABACAVIR HYPERSENSITIVITY AMONG NORTH INDIANS
    Kanga, Uma
    Sharma, Akanksha
    Alwadhi, Ajit
    Kapoor, Shashi
    Abid, Mohd.
    HLA, 2020, 95 (04) : 356 - 357
  • [7] Predisposition to abacavir hypersensitivity:: interest of HLA-B*57 genotyping in the Martinican cohort
    Bera, O.
    Abel, S.
    Cesaire, R.
    Paturel, L.
    Pierre-Francois, S.
    Cabie, A.
    TISSUE ANTIGENS, 2007, 69 (05): : 456 - 456
  • [8] Abacavir hypersensitivity testing: HLA-B*57 allelic typing is necessary in an ethnically heterogeneous population
    Burlinson, N. Diaz
    Hemmapour, S.
    Orkin, C.
    Sinnott, P.
    TISSUE ANTIGENS, 2007, 69 (05): : 460 - 460
  • [9] Abacavir adverse reactions related with HLA-B*57:01 haplotype in a large cohort of patients infected with HIV
    Quiros-Roldan, Eugenia
    Gardini, Giulia
    Properzi, Martina
    Ferraresi, Alice
    Carella, Graziella
    Marchi, Alessandro
    Malagoli, Alberto
    Foca, Emanuele
    Castelli, Francesco
    PHARMACOGENETICS AND GENOMICS, 2020, 30 (08): : 167 - 174
  • [10] HLA-B*57 genotyping in a Martinican cohort of HIV-infected patients and Abacavir hypersensitivity:: preliminary results
    Paturel, L.
    Abel, S.
    Nalpas, M.
    Cabie, A.
    Belon, P.
    Bera, O.
    TISSUE ANTIGENS, 2008, 71 (04): : 335 - 336